Gustafson H, Tribukait B, Esposti P L
Urol Res. 1982 Feb;10(1):13-8. doi: 10.1007/BF00256518.
229 patients with Grade 1-2 tumours (WHO), all category Ta or T1 (UICC) and surgically treated, were followed clinically and by flowcytofluorometric DNA-analysis (FCM). The tumours were characterised by their DNA profile. 175 cases were found to be diploid and fifty-four cases showed aneuploidy. The mean follow-up time with continuous FCM analysis was 2.6 years. During this period 19 patients showed tumour progression and 11 of these patients died. No progressive cases were found among 175 patients with repeatedly diploid DNA patterns. Thus tumour progression was exclusively linked to an aneuploid DNA pattern. In these case the degree of ploidy determined the frequency of progression: while 50% of the cases with triploid--hypotetraploid DNA pattern showed progression, only 10% of tumours with a tetraploid amount of DNA were found to be progressive. The degree of ploidy in 33 cases with recurrent aneuploid tumours was in general found to be constant. A fairly high degree of consistency was also found in the number of cells in S-phase, expressing proliferative properties. This indicates that superficial bladder tumours can be well characterised by their DNA profiles, that is the degree of ploidy and the proliferation pattern.
229例1 - 2级肿瘤(世界卫生组织分类)患者,均为Ta或T1期(国际抗癌联盟分类),且均接受了手术治疗,对其进行了临床随访以及流式细胞荧光DNA分析(FCM)。这些肿瘤通过其DNA图谱进行特征描述。发现175例为二倍体,54例显示非整倍体。持续进行FCM分析的平均随访时间为2.6年。在此期间,19例患者出现肿瘤进展,其中11例死亡。在175例DNA模式反复为二倍体的患者中未发现进展病例。因此,肿瘤进展仅与非整倍体DNA模式相关。在这些病例中,倍体程度决定了进展频率:三倍体 - 亚四倍体DNA模式的病例中有50%出现进展,而DNA含量为四倍体的肿瘤中只有10%被发现有进展。在33例复发性非整倍体肿瘤病例中,倍体程度总体上是恒定的。在表达增殖特性的S期细胞数量方面也发现了相当高的一致性。这表明浅表性膀胱肿瘤可以通过其DNA图谱,即倍体程度和增殖模式,得到很好的特征描述。